COVID-19 Vaccination Uptake and Hesitancy Among Current Tobacco Users

Novel mRNA vaccines have been developed and were first distributed to high-risk individuals (including smokers) in the United States starting in December 2020 to combat the coronavirus (COVID-19) pandemic. Over one-half of the U.S. adult population has received at least 1 dose of a COVID-19 vaccine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Krebs, Nicolle M, D’Souza, Gail, Bordner, Candace, Allen, Sophia I, Hobkirk, Andrea L, Foulds, Jonathan, Yingst, Jessica M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721404/
https://www.ncbi.nlm.nih.gov/pubmed/34987300
http://dx.doi.org/10.1177/1179173X211068027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721404/
https://www.ncbi.nlm.nih.gov/pubmed/34987300
http://dx.doi.org/10.1177/1179173X211068027

Ejemplares similares